VTE Prophylaxis (Medical Inpatients) — MRCP Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

Hard"Hematology"VTE Prophylaxis (Medical Inpatients)mrcp part 1

An adult with RAS-wild-type metastatic colorectal cancer has received fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, bevacizumab and cetuximab. Trifluridine-tipiracil with bevacizumab is unsuitable. Which oral treatment matches the current NICE third-line-or-later pathway?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

VTE Prophylaxis (Medical Inpatients) — MRCP Part 1 MCQ | iatroX